Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
7.0
100.10%
80%
—
30.31%
80%
—
5 Years
Score7.0
Net Growth100.10%
Net Trend80%
Net Income Consistency—
Rev Growth30.31%
Rev Trend80%
Revenue Consistency—
TherapeuticsMD Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 64M to $ 3M and net income went from -$ 183M to -$ 569K. Revenue increased in 4 of those 5 years; net income in 4.
Across TherapeuticsMD Inc's full reported history, from 2003 to 2025, revenue grew from $ 437.59K to $ 3M and net income went from $ 94.11K to -$ 569K. Revenue increased in 75% of the years measured; net income in 48%.
TherapeuticsMD Inc currently holds a 20-year HDB Score of 2.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.08 | — |
1 Year2025-08-12 | $ 1.11 | 87.39% |
5 Years2021-08-12 | $ 44.50 | -95.33% |
10 Years2016-08-12 | $ 362.00 | -99.43% |
20 Years2006-06-13 | $ 1.49 | 39.22% |
All Time2003-12-11 | $ 1.25 | 67.07% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-06-13 | All Time2003-12-11 |
|---|---|---|---|---|---|---|
| Price | $ 2.08 | $ 1.11 | $ 44.50 | $ 362.00 | $ 1.49 | $ 1.25 |
| Return | — | 87.39% | -95.33% | -99.43% | 39.22% | 67.07% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 3M | $ 179K | $ 8M |
| 2025 | $ 3M | -$ 569K | $ 7M |
| 2024 | $ 1M | -$ 2M | $ 5M |
| 2023 | $ 1M | -$ 10M | $ 4M |
| 2022 | $ 69M | $ 111M | $ 38M |
| 2021 | $ 2M | -$ 172M | $ 64M |
| 2020 | $ 64M | -$ 183M | $ 80M |
| 2019 | $ 49M | -$ 176M | $ 160M |
| 2018 | $ 16M | -$ 132M | $ 161M |
| 2017 | $ 16M | -$ 76M | $ 127M |
| 2016 | $ 19M | -$ 89M | $ 131M |
| 2015 | $ 20M | -$ 85M | $ 64M |
| 2014 | $ 15M | -$ 54M | $ 51M |
| 2013 | $ 8M | -$ 28M | $ 54M |
| 2012 | $ 3M | -$ 35M | $ 1M |
| 2011 | $ 2M | -$ 12M | $ 126.42K |
| 2010 | $ 48.22K | -$ 695.38K | $ 1.5K |
| 2009 | $ 10.57K | -$ 1M | $ 42.07K |
| 2008 | -$ 395.55K | $ 54.42K | |
| 2007 | $ 170.54K | $ 408.63K | |
| 2006 | $ 1M | $ 373.01K | $ 985.73K |
| 2005 | $ 934.52K | $ 289.89K | $ 902.26K |
| 2004 | $ 621.93K | $ 142.12K | $ 257.67K |
| IPO2003 | $ 437.59K | $ 94.11K | $ 280.39K |
Explore beyond TXMD
You're looking at TherapeuticsMD Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
